Searched for
MEDICAL JOURNAL MIMS
Pharma companies can’t sell tweaked drugs under old brand nameThe issue has been discussed for years now, and was deliberated in several Drugs Consultative Committee meetings held since 2008.- Gvernment bans sale of painkillerThe government has banned the sale of pain-relieving medicine, dextropropoxyphene, in a move that is expected to impact pharma companies' b...
- Overcharging set to cost pharma companies full sales revenue of drugA drug maker found overcharging will have to shell out the entire sales revenue of the medicine from the date of its launch as penalty, acc...
- Free samples to doctors to be now considered as taxable incomeDoctors getting free samples of medicines, gifts should now be prepared to pay tax as such freebies will be calculated as taxable income.
- Pharma department to meet drug firms to discuss making the drug marketing code mandatoryThe department of pharmaceuticals will meet drug manufacturers on July 18 to discuss making the drug marketing code mandatory.
- Drug marketing code may become mandatory soonDepartment of pharma will meet drug makers next month to discuss making a drug marketing code mandatory that aims to end the widespread une...
- Pharmaceutical companies including Cipla deny charges of collusion with drug regulator in drug trialsSeveral drug manufacturers accused of colluding with the sector regulator and medical experts to allegedly violate approval norms have deni...
- Natco seeks Pfizer nod for drug cloneIndian Pharma Co claims it can sell HIV drug at one-fifth the price.
- GSK stops Actified production to check abuseGlaxosmithkline Pharmaceuticals (GSK) India has stopped manufacturing its cold and cough drugs sold under the brand names Actified and Acti...
- GSK India abandons cold and cough drugsGlaxoSmithkline Pharmaceuticals(GSK) India has stopped manufacturing its cold and cough drugs sold under the brand name Actified and Actifi...
- Pay more for new asthma drugsIn an attempt to thwart price control, drug majors have withdrawn or reduced supplies of popular asthma drug Theophylline.
- Variation in bulk, retail prices to nail pharmasDrug makers governments will soon face tough questions from the drug price regulator.
Load More
